TSS
TEVA icon

Two Sigma Securities’s Teva Pharmaceuticals TEVA Stock Holding History

Two Sigma Securities’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-16,253
Closed -$284K – 3618
2024
Q2 		$264K Buy
+16,253
New +$250K ﹤0.01% 2110
2023
Q3 		– Sell
-15,494
Closed -$117K – 3468
2023
Q2 		$117K Sell
15,494
-77,963
-83% -$632K ﹤0.01% 2306
2023
Q1 		$827K Sell
93,457
-14,005
-13% -$138K 0.02% 940
2022
Q4 		$980K Buy
+107,462
New +$938K 0.03% 698
2022
Q3 		– Sell
-127,020
Closed -$1.12M – 3085
2022
Q2 		$955K Buy
127,020
+94,471
+290% +$823K 0.03% 553
2022
Q1 		$306K Buy
32,549
+19,978
+159% +$167K 0.01% 1389
2021
Q4 		$101K Sell
12,571
-41,574
-77% -$375K ﹤0.01% 1181
2021
Q3 		$527K Sell
54,145
-9,095
-14% -$85.2K 0.02% 747
2021
Q2 		$626K Buy
+63,240
New +$669K 0.02% 561
2020
Q4 		– Sell
-12,972
Closed -$124K – 1942
2020
Q3 		$117K Buy
12,972
+800
+7% +$8.46K ﹤0.01% 1168
2020
Q2 		$150K Sell
12,172
-3,837
-24% -$43.4K ﹤0.01% 1182
2020
Q1 		$144K Buy
16,009
+2,712
+20% +$27.8K ﹤0.01% 1103
2019
Q4 		$130K Buy
+13,297
New +$119K ﹤0.01% 2177
2019
Q3 		– Sell
-15,274
Closed -$141K – 2451
2019
Q2 		$141K Sell
15,274
-73,480
-83% -$886K ﹤0.01% 1802
2019
Q1 		$1.39M Buy
88,754
+72,071
+432% +$1.27M 0.01% 442
2018
Q4 		$257K Sell
16,683
-31,338
-65% -$642K ﹤0.01% 1512
2018
Q3 		$1.03M Buy
48,021
+37,062
+338% +$860K 0.01% 1014
2018
Q2 		$267K Sell
10,959
-53,590
-83% -$1.09M ﹤0.01% 2145
2018
Q1 		$1.1M Buy
64,549
+6,565
+11% +$128K 0.01% 1199
2017
Q4 		$1.1M Buy
+57,984
New +$872K 0.03% 399
2017
Q2 		– Sell
-16,595
Closed -$533K – 1173
2017
Q1 		$533K Sell
16,595
-10,388
-38% -$355K 0.1% 182
2016
Q4 		$978K Sell
26,983
-28,113
-51% -$1.12M 0.33% 57
2016
Q3 		$2.54M Buy
55,096
+48,111
+689% +$2.51M 0.86% 12
2016
Q2 		$351K Buy
6,985
+3,163
+83% +$168K 0.19% 153
2016
Q1 		$205K Buy
+3,822
New +$224K 0.26% 134

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Two Sigma Securities's TEVA Position: Q3 2024 in Review

Two Sigma Securities sold out of Teva Pharmaceuticals (TEVA) in Q3 2024, closing a stake of 16,253 shares — an estimated $284K sold.

Two Sigma Securities first reported a position in TEVA in Q1 2016 and held it in 25 quarters. The position peaked at $2.54M in Q3 2016. 542 funds tracked by Wall St. Rank hold TEVA as of Q3 2024.

  • Two Sigma Securities reported no remaining Teva Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Two Sigma Securities sold 16,253 Teva Pharmaceuticals shares in Q3 2024, an estimated $284K.
  • Two Sigma Securities first reported a position in Teva Pharmaceuticals in Q1 2016 and held it in 25 quarters.
  • Two Sigma Securities's Teva Pharmaceuticals position peaked at $2.54M in Q3 2016.
  • 542 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2024.

Based on Two Sigma Securities's 13F filing for Q3 2024, filed 14 Nov 2024.